Walgreens Clinical Trials Patient Engagement Strategy

This document is a guide that outlines Walgreens' approach to enhancing patient engagement in clinical trials. It describes how Walgreens leverages real-world data (RWD) and community relationships to improve enrollment rates, particularly among diverse populations. The guide details a Phase 3 randomized, observer-blind, placebo-controlled study aimed at evaluating the efficacy and safety of a vaccine in healthy female participants. Walgreens identifies eligible patients within a 20-mile radius of study sites, utilizing RWD insights to develop targeted digital outreach materials that cater to patients' preferred communication methods. The document emphasizes Walgreens' community-centered approach, noting that a significant portion of the U.S. population resides near their locations, including many in socially vulnerable areas. The guide also highlights the results achieved, including exceeding referral goals and increasing diverse patient participation compared to national averages. Overall, it presents Walgreens' commitment to making clinical trials more accessible and equitable.